Dr. Martin Mendoza

Martin Mendoza, PhD, is a public health and biomedical research leader with extensive experience in federal health policy, population health, clinical research, and precision medicine. He previously served as Director of the Office of Minority Health and Chief Population Health Officer at the Centers for Medicare & Medicaid Services (CMS), where he led efforts to advance optimal health outcomes through the development and integration of federal health policies and programs.

Prior to his tenure at CMS, Dr. Mendoza served as a Senior Scientist with the National Institutes of Health (NIH) *All of Us* Research Program, providing scientific leadership and expertise to strengthen rigor in precision medicine research. He also held a leadership role at the U.S. Food and Drug Administration (FDA), overseeing extramural research related to population health within the Office of the Commissioner.

A recognized expert in clinical trials, Dr. Mendoza has testified before Congress and was the primary author of influential FDA guidance recommending that clinical trial sponsors submit plans to strengthen the rigor of their studies. His original recommendation was subsequently incorporated into federal law in December 2022.

Throughout his career, Dr. Mendoza has held leadership and scientific positions across the U.S. Department of Health and Human Services and several NIH institutes, including the National Cancer Institute, the National Institute of Neurological Disorders and Stroke, and the National Human Genome Research Institute, where he contributed to work supporting the Human Genome Project.

Dr. Mendoza earned his bachelor's degree from the University of Maryland, Baltimore County, and his PhD in Cancer Biology from Johns Hopkins University.